Topic: Boehringer Ingelheim Gmbh
Evotec AG (Frankfurt:EVT) (TecDAX) today announced the completion of the squeeze-out process to acquire all of the remaining shares of DeveloGen AG...
Cancer patients relying on Johnson & Johnson's(JNJ) drug Doxil could continue facing shortages after a contract manufacturer suspended operations...
Posted on 10/06/11 at 11:32am by Joe Young . Piper Jaffray has published a research report on Gilead Sciences (NASDAQ: GILD ) after the company...
Posted on 09/07/11 at 9:03am by Abe Raymond . Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY ) will present the latest data from their...
If numbers tell a story, then Bayer (BAYN. PK) and Johnson & Johnson (JNJ) may have some explaining to do. The complete results of a widely...
PM360 Judges Announce 2011 Trailblazer Award Finalists. . Top Healthcare Talent, Companies and Brands to be Honored September 9th. New York, NY...
Posted on 06/15/11 at 9:01am by Benzinga Staff . Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY ) today announced...
Boehringer Ingelheim's Lead Hepatitis C Compound Moves into Phase 3 - the First Within the BI HCV Portfolio. Apr. 2, 2011 (PR Newswire) - . /*...
Two National Organizations Join DRIVE4COPD Movement to Raise Awareness of Nation's Fourth Leading Cause of Death. Mar. 15, 2011 (PR Newswire) -...
Hepregen Corporation Expands Agreement with Boehringer Ingelheim For The Adoption of HepatoPacTM. . Technology Platform Provides Pharmaceutical...
Video Gallery
-
Boehringer Ingelheim Pharma GmbH & Co. KG ...
Boehringer Ingelheim Pharma GmbH & Co. KG realizes advantages through efficient ...2011-05-12 -
Boehringer Ingelheim Pharma GmbH & Co. KG
Dr. med. Michael Schneider, Betriebsarzt2011-12-15 -
RheinBerg gegen Schlaganfall und Herzinfarkt
Im Ernstfall zählt jede Minute! Sowohl der Schlaganfall als auch ...2011-09-02
